Drug Profile
Diclofenac transdermal first generation - Crescita Therapeutics
Alternative Names: Diclofenac transdermal 1.5%; PennsaidLatest Information Update: 17 Dec 2021
Price :
$50
*
At a glance
- Originator Nuvo Research
- Developer Endo International; Gebro Pharma AG; Nuvo Research
- Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Musculoskeletal pain